Dyslipidaemia Flashcards
(22 cards)
What is the line treatment for hypercholesterolaemia and moderate hypertriglyceridaemia?
statins
for severe HC and HT: statins + ezetimibe
What is the line treatment for familial hypercholesterolaemia?
high intensity statin ( >40% LDL-C reduction)
if it is primary heterozygous familial hypercholesterolaemia
- statins or ezetimibe monotherapy if CI or combination
- fibrate or a bile acid sequestrant (such as colestyramine or colestipol hydrochloride) if the above are CI
if it is primary homoozygous familial hypercholesterolaemia
- specialist advice
What combination of statin and fibre should be avoided and why?
statin + gemfibrozil (esp simvastatin)
- increased rhabdomyolysis risk
When are fibrates used?
if triglycerides remain high even after the LDL-cholesterol concentration has been reduced adequately.
When are PCSK9 inhibitors used in hypercholesterolaemia? Examples?
patients with primary heterozygous familial hypercholesterolaemia whose LDL-cholesterol has not been adequately controlled on maximum tolerated lipid-lowering therapy
alirocumab and evolocumab
What is the lipid reduction target?
- high risk patients: LDL-C and non-HDL-C
LDL-C < 2mmol/L
non-HDL-C < 2.6mmol/L
When are statins CI?
pregnancy and breastfeeding
active liver disease
unexplained raised transaminases
What is the MHRA warning for statins?
new-onset, or exacerbation of pre-existing, myasthenia gravis or ocular myasthenia associated with statin use
symptoms: weakness in the arms or legs that worsens after activity, double vision, drooping of the eyelids, difficulty swallowing, or shortness of breath
Which statins can be taken at any time of day?
atorvastatin
rosuvastatin
What are the cautions for statin use?
muscle toxicity
hypothyroidism: should be managed before starting statin use
What are the main side effects for statins?
muscle effects: myalgia, myopathy, myositis, and rhabdomyolysis
- muscle pain, weakness, or cramps
- measure creatine kinase: if > 5x the upper limits then discontinue
diabetes: can raise blood glucose concentration
- do not discontinue as benefit > risk
interstitial lung disease: dyspnoea, cough, and weight loss
- red flag, seek help
Can statins be used in pregnancy?
contraception is required during treatment and for 1 month afterwards
avoid during pregnancy: discontinue 3 months before attempting to conceive
How does hepatic impairment affect statin use?
avoid in active liver disease, unexplained raised transaminase > 3x upper limit, discontinue
What counselling points are needed for statins?
interstitial lung disease
- report dyspnoea, cough, and weight loss
myopathy, myalgia, rhabdomylosis
- report muscle pain, weakness, or cramps
What monitoring is needed for statins?
baseline lipid profile: repeated 2–3 months after starting or changing treatment
baseline TSH
renal function
liver function: before starting treatment with statins, repeated 2–3 months after starting or changing treatment, and then at 12 months
fasting blood glucose: before starting statin treatment, and then repeated after 3 months.
When should creatine kinase be measured during statin use?
before use IF: persistent, generalised, unexplained muscle pain, tenderness or weakness
during use if they DEVELOP: unexplained muscle pain, tenderness or weakness
discontinue if repeated >5x the upper limit
What are the main drug interactions for statins?
enzyme inhibitors: increased statin concentration therefore increased myopathy risk
macrolide antibiotics: stop taking statins until course is finished
fusidic acid: restart after last dose
rosuvastatin + warfarin: increased anticoagulant effect/bleeding risk
When should simvastatin be dose reduced?
bezafibrate, ciprofibrate: max 10mg OD
amiodarone, amlodipine, ranolazine: max 20mg OD
verapamil, diltiazem: max 20mg OD
ticagrelor, lomitapide: max 40mg OD
When should atorvastatin be dose reduced?
ciclosporin: max 10mg OD
antivirals: max 20mg OD
When should rosuvastatin be dose reduced?
leflunomide: max 10mg OD
clopidogrel: initially 5mg OD then max 20mg OD
When are fibrates CI?
gallbladder disease
pancreatitis
What is the target level for healthy vs high risk patients?
total cholesterol
LDL-C
HDL-C
non-HDL
triglycerides
total cholesterol
- <5mmol/L vs <4mmol/L
LDL-C
- <3mmol/L vs <2mmol/L
HDL-C
- >1mmol/L (M), >1.2mmol/L (F)
non-HDL
- <4mmol/L vs <2.6mmol/L
triglycerides
- <1.7mmol/L
- < 2.3mmol/L (fasting TG)